BioWorld

April 7, 2003

View Archived Issues

Administration Won't Reimburse Failed Project BioShield Drugs

Senior Bush administration officials said companies contracted to develop biomedical countermeasures under Project BioShield would not receive full government payment until the FDA approved their products. (BioWorld Today) Read More

For Biotech, Speaker Declares: 'I've Never Seen A Better Time'

Read More

Palindromic DNA Sequence Allows p53 Target Genes To Kill Off Cancer Cells & Suppress Tumor Formation

Read More

Deltagen Gains At Least $10M In Private Financing Commitment

Read More

Correction

Read More

Memantine Improves Cognition When Combined With Aricept

Read More

Affymetrix Stock Falls Fast As It Projects Lower Product Revenue

Read More

Other News To Note

Read More